• Login
    View Item 
    •   Home
    • Graduate Theses, Dissertations and Projects
    • Queen's Graduate Theses and Dissertations
    • View Item
    •   Home
    • Graduate Theses, Dissertations and Projects
    • Queen's Graduate Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People with Major Depression and/or Generallzed Anxiety Disorder

    Thumbnail
    View/Open
    Thesis Document (4.452Mb)
    Author
    Chinna Meyyappan, Arthi
    Metadata
    Show full item record
    Abstract
    Objective: The primary objective of this study is to assess subjective changes in mood and anxiety symptoms before, during, and after administration of the microbial therapeutic. The secondary objectives of this study are to assess changes in diversity of gut microbiome, changes in peripheral blood biomarkers, repopulation of healthy gut bacteria, and safety and tolerability of therapeutic.

    Method: Twelve adults diagnosed with major depressive disorder or generalized anxiety disorder were recruited from the Kingston area. Participants orally consumed once daily an encapsulated microbial therapeutic, containing 40 strains of bacteria purified and lab-grown from a single healthy donor stool, for 8 weeks. Participants underwent a series of clinical assessments measuring mood, anxiety, and gastrointestinal (GI) symptoms using validated clinical scales and questionnaires. Molecular data was collected from blood and fecal samples to assess metabolic changes, neurotransmitter, immunoglobulin, and inflammatory markers concentrations, and alpha diversity for fecal samples to predict outcomes in depression or anxiety.

    Results: Of the twelve individuals included in this study, nine have responded to treatment (50% improvement in MADRS and/or GAD-7 scores from baseline to week 8 visit). Over the course of 10 weeks MET-2 significantly decreased MADRS and GAD-7 scores, MADRS [F (5, 55) = 8.784, p<0.001 and F(2.78,30.56) = 9.638, p<0.01], respectively. This improvement may be mediated by the recolonization of the gastrointestinal tract with healthy bacteria resulting in increased bacterial diversity. Although increased bacterial diversity was seen in participants’ stool samples from baseline (3.62  0.20) to week 8 (3.69  0.13), this increase was not significant (p=0.104). Results for peripheral blood biomarkers showed a significant decrease in overall HDL, IgM, and IgG concentrations.No significant change was seen in alpha diversity during stool analysis.

    Conclusion: The findings of this study are the first to provide evidence for the role of microbial ecosystem therapy in treating depression and anxiety. However, a double-blind, randomized controlled trial with a larger sample size is needed for more conclusive results.
    URI for this record
    http://hdl.handle.net/1974/27886
    Collections
    • Centre for Neuroscience Studies Graduate Theses
    • Queen's Graduate Theses and Dissertations
    Request an alternative format
    If you require this document in an alternate, accessible format, please contact the Queen's Adaptive Technology Centre

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us
    Theme by 
    Atmire NV
     

     

    Browse

    All of QSpaceCommunities & CollectionsPublished DatesAuthorsTitlesSubjectsTypesThis CollectionPublished DatesAuthorsTitlesSubjectsTypes

    My Account

    LoginRegister

    Statistics

    View Usage StatisticsView Google Analytics Statistics

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us
    Theme by 
    Atmire NV